Waverley Pharma Inc. (TSXV:WAVE)
Canada
· Delayed Price · Currency is CAD 0.0250
+0.0100 (66.67%)
Mar 9, 2026, 2:36 PM EST
Waverley Pharma Company Description
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.
The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States.
Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Waverley Pharma Inc.
| Country | Canada |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Larry Thiessen |
Contact Details
Address: 4-1250 Waverley Street Winnipeg, MB R3T 6C6 Canada | |
| Phone | 204 928 7907 |
| Website | waverleypharma.com |
Stock Details
| Ticker Symbol | WAVE |
| Exchange | TSX Venture Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA94357L1058 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Larry Thiessen M.B.A. | President, Chief Executive Officer and Director |
| Haaris Uddin B.Com., CPA | Chief Financial Officer |